Cargando…
What’s new in kidney tumor pathology 2022: WHO 5th edition updates
The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduces significant changes relevant to daily practice, especially in the completely restructured renal cell tumor chapters. Herein we highlight the most important diagnostic updates of known kidney tumor types, new and...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682217/ https://www.ncbi.nlm.nih.gov/pubmed/36069072 http://dx.doi.org/10.4132/jptm.2022.08.16 |
| _version_ | 1784834801617862656 |
|---|---|
| author | Tretiakova, Maria |
| author_facet | Tretiakova, Maria |
| author_sort | Tretiakova, Maria |
| collection | PubMed |
| description | The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduces significant changes relevant to daily practice, especially in the completely restructured renal cell tumor chapters. Herein we highlight the most important diagnostic updates of known kidney tumor types, new and molecularly defined entities and emerging/provisional entities. |
| format | Online Article Text |
| id | pubmed-9682217 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Korean Society of Pathologists and the Korean Society for Cytopathology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96822172022-12-05 What’s new in kidney tumor pathology 2022: WHO 5th edition updates Tretiakova, Maria J Pathol Transl Med Newsletter The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduces significant changes relevant to daily practice, especially in the completely restructured renal cell tumor chapters. Herein we highlight the most important diagnostic updates of known kidney tumor types, new and molecularly defined entities and emerging/provisional entities. The Korean Society of Pathologists and the Korean Society for Cytopathology 2022-11 2022-09-08 /pmc/articles/PMC9682217/ /pubmed/36069072 http://dx.doi.org/10.4132/jptm.2022.08.16 Text en © 2022 The Korean Society of Pathologists/The Korean Society for Cytopathology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Newsletter Tretiakova, Maria What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title | What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title_full | What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title_fullStr | What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title_full_unstemmed | What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title_short | What’s new in kidney tumor pathology 2022: WHO 5th edition updates |
| title_sort | what’s new in kidney tumor pathology 2022: who 5th edition updates |
| topic | Newsletter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682217/ https://www.ncbi.nlm.nih.gov/pubmed/36069072 http://dx.doi.org/10.4132/jptm.2022.08.16 |
| work_keys_str_mv | AT tretiakovamaria whatsnewinkidneytumorpathology2022who5theditionupdates |